Neuburgh Advisers LLC boosted its position in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 1.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 304,172 shares of the real estate investment trust’s stock after acquiring an additional 3,652 shares during the quarter. Neuburgh Advisers LLC owned 0.08% of Medical Properties Trust worth $4,891,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Magnus Financial Group LLC bought a new position in shares of Medical Properties Trust in the fourth quarter valued at about $256,000. Brown Advisory Inc. raised its position in shares of Medical Properties Trust by 26.1% in the fourth quarter. Brown Advisory Inc. now owns 154,598 shares of the real estate investment trust’s stock valued at $2,486,000 after purchasing an additional 31,989 shares during the period. Natixis Advisors L.P. bought a new position in shares of Medical Properties Trust in the fourth quarter valued at about $211,000. Flinton Capital Management LLC raised its position in shares of Medical Properties Trust by 1.2% in the fourth quarter. Flinton Capital Management LLC now owns 470,084 shares of the real estate investment trust’s stock valued at $7,559,000 after purchasing an additional 5,644 shares during the period. Finally, Kepos Capital LP bought a new position in shares of Medical Properties Trust in the fourth quarter valued at about $1,470,000. 76.94% of the stock is currently owned by hedge funds and other institutional investors.
Several brokerages have recently weighed in on MPW. Mitsubishi UFJ Financial Group increased their price objective on shares of Medical Properties Trust to $17.00 and gave the company a “neutral” rating in a research report on Monday, February 11th. SunTrust Banks downgraded shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a research note on Tuesday, December 18th. Jefferies Financial Group upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating and upped their price target for the company from $18.00 to $23.00 in a research note on Wednesday, February 13th. JPMorgan Chase & Co. upgraded shares of Medical Properties Trust from a “neutral” rating to an “overweight” rating in a research note on Wednesday, December 19th. Finally, Wells Fargo & Co upgraded shares of Medical Properties Trust from an “underperform” rating to a “market perform” rating and upped their price target for the company from $13.50 to $17.50 in a research note on Tuesday, December 11th. Six research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $16.75.
MPW stock opened at $18.49 on Tuesday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.92 and a current ratio of 5.22. Medical Properties Trust, Inc. has a 52 week low of $12.25 and a 52 week high of $18.60. The stock has a market capitalization of $6.85 billion, a P/E ratio of 13.50, a price-to-earnings-growth ratio of 3.36 and a beta of 0.72.
Medical Properties Trust (NYSE:MPW) last released its quarterly earnings results on Thursday, February 7th. The real estate investment trust reported $0.31 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.31. Medical Properties Trust had a net margin of 129.59% and a return on equity of 8.83%. The business had revenue of $180.60 million for the quarter, compared to the consensus estimate of $179.68 million. During the same period in the prior year, the company posted $0.37 earnings per share. Medical Properties Trust’s revenue was down 11.9% compared to the same quarter last year. On average, analysts predict that Medical Properties Trust, Inc. will post 1.43 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 11th. Investors of record on Thursday, March 14th will be paid a $0.25 dividend. The ex-dividend date of this dividend is Wednesday, March 13th. This represents a $1.00 annualized dividend and a dividend yield of 5.41%. Medical Properties Trust’s dividend payout ratio (DPR) is presently 72.99%.
In related news, VP James Kevin Hanna sold 18,000 shares of the company’s stock in a transaction dated Monday, February 11th. The shares were sold at an average price of $18.37, for a total value of $330,660.00. Following the transaction, the vice president now directly owns 76,318 shares in the company, valued at $1,401,961.66. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.83% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2019/03/12/neuburgh-advisers-llc-has-4-89-million-holdings-in-medical-properties-trust-inc-mpw.html.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Read More: What is the Rule of 72?
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.